A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis

NCT03324503 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoidosis, Pulmonary

Interventions

DRUG: Glucocorticoid (prednisone or prednisolone)

Sponsor

Celgene